Inhibition of alpha(5)beta(1)integrin with the clinically validated small peptide, ATN-161 stabilizes cerebral vasculature, reduces inflammation, and decreases blood-brain barrier permeability after experimental ischemic stroke

Danielle Edwards, Katie Salmeron, Douglas Lukins, Amanda Trout, Justin Fraser, Gregory Bix

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
JournalFASEB Journal
Volume33
StatePublished - Apr 2019

Fingerprint

Dive into the research topics of 'Inhibition of alpha(5)beta(1)integrin with the clinically validated small peptide, ATN-161 stabilizes cerebral vasculature, reduces inflammation, and decreases blood-brain barrier permeability after experimental ischemic stroke'. Together they form a unique fingerprint.

Cite this